Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Ionis Pharmaceuticals Inc. buy JPMorgan Chase & Co.

Ionis Pharmaceuticals Inc.
Start price
€59.76
08.10.25 / 50%
Target price
€68.81
08.10.26
Performance (%)
-18.26%
Price
€48.85
07.08.26
Summary
This prediction is currently active. The price of Ionis Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -18.26%. This prediction currently runs until 08.10.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Ionis Pharmaceuticals Inc. 2.294% 2.294%
iShares Core DAX® 1.842% 1.387%
iShares Nasdaq 100 4.659% -1.797%
iShares Nikkei 225® 3.963% -5.216%
iShares S&P 500 3.700% 1.576%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread Ionis Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -18.26%
Target price 68.808
Change
Ends at 08.10.26

Ionis Pharmaceuticals (NASDAQ:IONS) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $80.00 price target on the stock, up previously from $49.00.
Ratings data for IONS provided by MarketBeat

JPMorgan Chase & Co. 
0
Report Share
08.10.25

Stopped prediction by JPMorgan_Chase___Co_ for Ionis Pharmaceuticals Inc.

buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€46.55
03.08.26
€65.92
03.08.27
4.94%
07.08.26

JPMorgan Chase & Co. 
03.08.26 50%